99 studies found for:    "Biliary tract cancer"
Show Display Options
Rank Status Study
1 Terminated Randomized Trial of Gemcitabine/Cisplatin Versus S-1/Cisplatin in Advanced Biliary Cancer
Conditions: Metastatic Biliary Tract Cancer;   Locally Advanced Biliary Tract Cancer
Interventions: Drug: Gemcitabine, Cisplatin;   Drug: S-1, Cisplatin
2 Unknown  Second Line Therapy in Advanced Biliary Tract Cancer
Condition: Biliary Tract Cancer
Interventions: Drug: capecitabine and mitomycin;   Drug: Capecitabine
3 Active, not recruiting A Study of Combination of Gemcitabine, Oxaliplatin (GEMOX)-Sorafenib in Patients With Advanced Biliary Tract Cancer
Conditions: Cholangiocarcinoma;   Biliary Tract Cancer;   Gallbladder Cancer
Interventions: Drug: Gemcitabine;   Drug: Oxaliplatin;   Drug: Sorafenib
4 Unknown  Docetaxel and Oxaliplatin Combination With Locally Advanced or Metastatic Biliary Tract Cancer
Condition: Biliary Tract Cancer
Intervention: Drug: Docetaxel, Oxaliplatin
5 Active, not recruiting Phase I Study of Gemcitabine or S-1 Adjuvant Therapy After Hemihepatectomy for Biliary Tract Cancer
Condition: Biliary Tract Cancer
Interventions: Drug: Gemcitabine;   Drug: S-1
6 Recruiting Phase II Study of Gemcitabine Versus S-1 Adjuvant Therapy After Hemihepatectomy for Biliary Tract Cancer
Condition: Biliary Tract Cancer
Interventions: Drug: Gemcitabine;   Drug: S-1
7 Completed
Has Results
Randomized Phase 2 Study With Gemcitabine Alone and Combination Therapy for Patients With Advanced Biliary Tract Cancer
Condition: Biliary Tract Cancer
Interventions: Drug: gemcitabine;   Drug: cisplatin
8 Recruiting Oral Rehydration Therapy for Short Hydration in Chemotherapy With CDDP Plus GEM for Biliary Tract Cancer
Condition: Biliary Tract Cancer
Interventions: Drug: Gemcitabine , Cisplatin, Oral Rehydration Solution (ORS);   Drug: Gemcitabine , Cisplatin
9 Unknown  Phase II Study of FOLFOXIRI in Patients With Locally Advanced or Metastatic Biliary Tract Cancer
Condition: Biliary Tract Cancer
Interventions: Drug: Fluorouracil;   Drug: Leucovorin;   Drug: Oxaliplatin;   Drug: Irinotecan
10 Completed Case Series Study of Biliary Tract Cancer Patients in Japan
Condition: Biliary Tract Cancer
Intervention:
11 Active, not recruiting Gemcitabine/Cisplatin/S-1(GCS) Combination Therapy for Patients With Advanced Biliary Tract Cancer
Condition: Biliary Tract Cancer
Intervention: Drug: S-1, Gemcitabine, Cisplatin
12 Completed
Has Results
Vandetanib Gemcitabine Or Placebo Plus Gemcitabine Or Vandetanib Monotherapy In Advanced Biliary Tract Cancer
Conditions: Biliary Tract Cancer;   Gallbladder Cancer;   Cancer Of The Extrahepatic Bile Duct;   Ampullary Carcinoma
Interventions: Drug: ZD6474, Vandetanib;   Drug: Gemcitabine;   Drug: Placebo matching ZD6474
13 Active, not recruiting A Phase I Study of Adjuvant Chemotherapy With GC in Biliary Tract Cancer Undergoing Resection Without Major Hepatectomy
Condition: Biliary Tract Cancer
Intervention: Drug: gemcitabine , cisplatin
14 Recruiting A Phase I Study of Adjuvant Chemotherapy With GS in Biliary Tract Cancer Undergoing Resection Without Major Hepatectomy
Condition: Biliary Tract Cancer
Intervention: Drug: Gemcitabine, S-1
15 Unknown  Study of S-1 Oxaliplatin (SOX) for Biliary Tract Cancer (BTC) (Ampullary Adenocarcinoma)
Condition: Biliary Tract Cancer
Intervention: Drug: S-1 oxaliplatin
16 Enrolling by invitation Vessel Resection and Reconstruction of Biliary Tract Cancers
Condition: Biliary Tract Cancer
Intervention:
17 Recruiting Active Symptom Control Alone or With mFOLFOX Chemotherapy for Locally Advanced/ Metastatic Biliary Tract Cancers
Conditions: Biliary Tract Cancer;   Gallbladder Cancer;   Cholangiocarcinoma;   Ampullary Cancer
Interventions: Other: Active Symptom Control;   Drug: L-folinic acid;   Drug: 5 FU;   Drug: Oxaliplatin
18 Completed A Population-Based Case-Control Study of Biliary Tract Cancers in Shanghai, China
Condition: Biliary Tract Cancer
Intervention:
19 Recruiting GAMBIT Trial: Cisplatin Plus Irinotecan in the Treatment of Gallbladder or Biliary Tract Cancer
Condition: Biliary Cancer
Interventions: Drug: Irinotecan;   Drug: Cisplatin;   Drug: Gemcitabine
20 Active, not recruiting Selumetinib in Treating Patients With Biliary Cancer That Cannot Be Removed By Surgery
Conditions: Liver and Intrahepatic Biliary Tract Cancer;   Recurrent Extrahepatic Bile Duct Cancer;   Unresectable Extrahepatic Bile Duct Cancer
Interventions: Drug: selumetinib;   Other: laboratory biomarker analysis

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years